European Commission gives OK to big Siemens/Varian deal February 19, 2021 -- The European Commission (EC) has given its blessing to the bid by Siemens Healthineers to acquire radiation oncology firm Varian Medical Systems. The EC approved the deal after Siemens gave assurances that it would keep its systems open to third parties.Read More
Radionuclide therapy, immunotherapy can slow prostate cancer February 9, 2021 -- Pairing radionuclide therapy with immunotherapy can successfully slow prostate cancer progression and increases survival time, according to new research published in the February edition of the Journal of Nuclear Medicine.Read More
Hologic touts BioZorb breast tissue marker February 4, 2021 -- Hologic is highlighting a study that found its BioZorb 3D tissue marker to be a safe adjunct to breast-conserving surgery and radiation therapy in patients with breast cancer.Read More
Aikido invests in prostate radiopharma firm February 2, 2021 -- Aikido Pharma has made an investment in Convergent Therapeutics, a company developing a radiopharmaceutical for treating prostate cancer. Aikido made the investment in the form of a $2 million convertible promissory note purchase agreement.Read More
ASTRO endorses COVID-19 vaccine for cancer patients January 29, 2021 -- The American Society for Radiation Oncology (ASTRO) has updated its COVID-19 clinical guidance to include support for vaccination as long as the cancer patient does not have increased risk of a reaction.Read More
Radiation oncology has some of the lowest numbers when it comes to female senior faculty representation, according to research published in JAMA Network Open. Read more